,"the class of nucleotide analogs, has shown potent effect in",quick recovery of the COVID-19 patients (50). In a recent
0,treating Ebola virus and Marburg virus infections (47).,"clinical trial study, patients with confirmed COVID-19"
1,Remdesivir was developed by Gilead Sciences for the,infection were treated with compassionate use of remdesivir
2,treatment of viral diseases caused by various RNA viruses.,"for 10 days (51). On day 1, patients were treated intrave-"
